Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma

NCT05124002 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma, Intrahepatic

Interventions

DRUG: Recombinant Human Adenovirus Type 5
DRUG: HAIC of FOLFOX

Sponsor

Beijing Tsinghua Chang Gung Hospital